scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF00685599 |
P698 | PubMed publication ID | 1394803 |
P2093 | author name string | Z. Agur | |
L. E. Harnevo | |||
P2860 | cites work | Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage | Q28272540 |
Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas. | Q34260669 | ||
Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma | Q34266766 | ||
Gene amplification, drug resistance, and cancer. | Q34267175 | ||
A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate | Q34702164 | ||
DNA amplification is rare in normal human cells | Q37709503 | ||
Normal diploid human and rodent cells lack a detectable frequency of gene amplification | Q37742113 | ||
Recent progress in understanding mechanisms of mammalian DNA amplification | Q38648620 | ||
Multidrug-resistance phenotype in Chinese hamster ovary cells | Q40159830 | ||
Gene amplification in cultured animal cells | Q40182130 | ||
Gene amplification | Q40186634 | ||
The importance of dose intensity in chemotherapy of metastatic breast cancer | Q40190080 | ||
Transposition of human immunoglobulin V kappa genes within the same chromosome and the mechanism of their amplification | Q41210065 | ||
Amplification of the int-2 gene in human head and neck squamous cell carcinomas | Q41732211 | ||
Isolation and characterization of an adriamycin-resistant breast tumor cell line | Q41733228 | ||
Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines | Q41736961 | ||
Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts | Q41737160 | ||
myc gene amplification and expression in primary human neuroblastoma | Q41741752 | ||
Amplification and expression of a multidrug resistance gene in human glioma cell lines | Q41750766 | ||
Amplification and expression of c-Ki-ras oncogene in human ovarian cancer | Q41757168 | ||
Effect of the dosing interval on myelotoxicity and survival in mice treated by cytarabine | Q43621931 | ||
High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer | Q43666509 | ||
Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients | Q43954893 | ||
A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs | Q46308140 | ||
The dynamics of gene amplification described as a multitype compartmental model and as a branching process | Q52457171 | ||
A mathematical model of the development of drug resistance to cancer chemotherapy. | Q52589158 | ||
Quantitative model for multiple levels of drug resistance in clinical tumors. | Q52701545 | ||
The polymerase chain reaction and rapid antibiotic resistance screening. | Q54313914 | ||
Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas. | Q54324024 | ||
A mathematical model of drug resistance applied to treatment for small-cell lung cancer. | Q54388385 | ||
Rationale for the use of alternating non-cross-resistant chemotherapy. | Q54520436 | ||
HER-2/neu amplification predicts poor survival in node-positive breast cancer | Q68091225 | ||
Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer | Q68420205 | ||
Amplification of the genes for both components of ribonucleotide reductase in hydroxyurea resistant mammalian cells | Q68495805 | ||
Gene amplification in gastric and esophageal adenocarcinomas | Q68920865 | ||
Impact of dose-intense chemotherapy on the development of permanent drug resistance | Q69457915 | ||
An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene | Q69918341 | ||
Zidovudine toxicity to murine bone marrow may be affected by the exact frequency of drug administration | Q70146632 | ||
Dose: a critical factor in cancer chemotherapy | Q72154949 | ||
Multidrug resistance | Q72583621 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 469-476 | |
P577 | publication date | 1992-01-01 | |
P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
P1476 | title | Drug resistance as a dynamic process in a model for multistep gene amplification under various levels of selection stringency | |
P478 | volume | 30 |
Q41189037 | A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures |
Q52261519 | Conflicting objectives in chemotherapy with drug resistance |
Q41439654 | Drug-induced DNA hypermethylation: a potential mediator of acquired drug resistance during cancer chemotherapy |
Q39312575 | Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical model |
Q33758382 | Evolution of acquired resistance to anti-cancer therapy |
Q28478165 | Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia |
Q37358959 | Long range personalized cancer treatment strategies incorporating evolutionary dynamics |
Q37613826 | Mathematical modeling as a tool for planning anticancer therapy. |
Q38160282 | Mathematical models for translational and clinical oncology |
Q52070002 | Optimal control for a stochastic model of cancer chemotherapy. |
Q33769175 | Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models |
Q35857502 | The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells |
Q40521314 | The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling. |
Q52011476 | The effect of heterogeneity on optimal regimens in cancer chemotherapy. |
Q52380253 | Time-continuous branching walk models of unstable gene amplification. |
Q40488661 | Use of mathematical models for understanding the dynamics of gene amplification |